Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34 USD | -4.72% | -12.29% | -77.50% |
05-10 | Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates | MT |
04-25 | Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-77.50% | 541M | |
+26.32% | 44.96B | |
-0.84% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.51% | 26.08B | |
-21.21% | 19.03B | |
+5.98% | 12.75B | |
+28.51% | 12.06B | |
-3.33% | 11.75B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Transcript : Biohaven Pharmaceutical Holding Company Ltd., Q3 2021 Earnings Call, Nov 09, 2021